SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-055663
Filing Date
2023-07-10
Accepted
2023-07-10 08:43:51
Documents
6
Period of Report
2023-07-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea181539-6k_incannex.htm 6-K 19672
2 ASX ANNOUNCEMENT, DATED JULY 10, 2023 - IHL INTENDS TO REDOMICILE TO US ANNOUNCE ea181539ex99-1_incannex.htm EX-99.1 776369
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3328
4 GRAPHIC ex99-1_002.jpg GRAPHIC 3828
5 GRAPHIC ex99-1_003.jpg GRAPHIC 2962
6 GRAPHIC ex99-1_004.jpg GRAPHIC 4228
  Complete submission text file 0001213900-23-055663.txt   817425
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Ltd (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-41106 | Film No.: 231078319
SIC: 2834 Pharmaceutical Preparations